Chr | chr17 |
start | 59841266 |
end | 59841337 |
ID | MI0000077 |
miRNA_name | hsa-miR-21 |
methods | qRT-PCR,etc. |
regulated | up |
Function Description | Upregulation of miR-21 expression at diagnosis was determined as an average miR-21 expression in healthy women plus 2xSD as described at the Material and Methods. Progression-free survival was compared between patients with and without miR-21 upregulation at diagnosis. Patients with miR-21 upregulation showed shorter progression-free survival, median survivals were 72 vs 86 weeks and Mantel-Cox test p=0.049, Fig |
PMID | 31030498 |
year | 2019 |
Title | Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer |
drug | X |
circulating | V |
survival | V |
CopyRight © University of Miami, USA; Harbin Medical University, China